

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | activated T cell proliferation (GO:0050798) | 5.17674238 |
| 2 | negative thymic T cell selection (GO:0045060) | 4.64954507 |
| 3 | negative regulation of cAMP-mediated signaling (GO:0043951) | 4.64464808 |
| 4 | negative T cell selection (GO:0043383) | 4.47691133 |
| 5 | interferon-gamma production (GO:0032609) | 4.39043589 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.99075584 |
| 7 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.82368692 |
| 8 | negative regulation of T cell mediated immunity (GO:0002710) | 3.75509036 |
| 9 | histone mRNA catabolic process (GO:0071044) | 3.75123034 |
| 10 | histone H3-K4 trimethylation (GO:0080182) | 3.62865558 |
| 11 | dopamine biosynthetic process (GO:0042416) | 3.61974437 |
| 12 | negative regulation of cell killing (GO:0031342) | 3.46962548 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.46962548 |
| 14 | regulation of cilium movement (GO:0003352) | 3.40596518 |
| 15 | positive regulation of protein homooligomerization (GO:0032464) | 3.33994580 |
| 16 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 3.30270328 |
| 17 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 3.30270328 |
| 18 | indolalkylamine metabolic process (GO:0006586) | 3.28127677 |
| 19 | mRNA splice site selection (GO:0006376) | 3.26406178 |
| 20 | T cell selection (GO:0045058) | 3.24854158 |
| 21 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.20537835 |
| 22 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.20462559 |
| 23 | tolerance induction (GO:0002507) | 3.19929184 |
| 24 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.18468599 |
| 25 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.18021936 |
| 26 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.18021936 |
| 27 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.17707607 |
| 28 | serotonin metabolic process (GO:0042428) | 3.16732052 |
| 29 | mitochondrion transport along microtubule (GO:0047497) | 3.16228065 |
| 30 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.16228065 |
| 31 | forebrain neuron differentiation (GO:0021879) | 3.15598764 |
| 32 | retinal rod cell development (GO:0046548) | 3.14675415 |
| 33 | positive T cell selection (GO:0043368) | 3.14604752 |
| 34 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.13231305 |
| 35 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.13231305 |
| 36 | thymic T cell selection (GO:0045061) | 3.09076074 |
| 37 | alkaloid metabolic process (GO:0009820) | 3.08304001 |
| 38 | establishment of mitochondrion localization (GO:0051654) | 3.07695695 |
| 39 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.07664951 |
| 40 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.04511280 |
| 41 | negative regulation of mast cell activation (GO:0033004) | 3.03488277 |
| 42 | positive regulation of granulocyte differentiation (GO:0030854) | 3.02651053 |
| 43 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.01476564 |
| 44 | regulation of gamma-delta T cell activation (GO:0046643) | 2.97954013 |
| 45 | RNA destabilization (GO:0050779) | 2.94200812 |
| 46 | detection of light stimulus involved in visual perception (GO:0050908) | 2.91214999 |
| 47 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.91214999 |
| 48 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.90444221 |
| 49 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.90444221 |
| 50 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.90444221 |
| 51 | RNA localization (GO:0006403) | 2.90087293 |
| 52 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.88374776 |
| 53 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.87035706 |
| 54 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.86881727 |
| 55 | negative regulation of telomere maintenance (GO:0032205) | 2.85705214 |
| 56 | behavioral response to nicotine (GO:0035095) | 2.85272958 |
| 57 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.84840195 |
| 58 | leukocyte aggregation (GO:0070486) | 2.84138544 |
| 59 | primary amino compound metabolic process (GO:1901160) | 2.83305059 |
| 60 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.83158780 |
| 61 | histone deubiquitination (GO:0016578) | 2.81666702 |
| 62 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.77936572 |
| 63 | negative regulation of adaptive immune response (GO:0002820) | 2.77433988 |
| 64 | regulation of telomere maintenance (GO:0032204) | 2.75858962 |
| 65 | olfactory bulb development (GO:0021772) | 2.75357016 |
| 66 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.74257933 |
| 67 | positive regulation of mRNA catabolic process (GO:0061014) | 2.73861452 |
| 68 | Peyers patch development (GO:0048541) | 2.73646232 |
| 69 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.73646232 |
| 70 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.67926070 |
| 71 | response to interleukin-15 (GO:0070672) | 2.67384006 |
| 72 | nonmotile primary cilium assembly (GO:0035058) | 2.67327657 |
| 73 | positive thymic T cell selection (GO:0045059) | 2.64929659 |
| 74 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.62329879 |
| 75 | cellular response to interleukin-15 (GO:0071350) | 2.60305427 |
| 76 | natural killer cell differentiation (GO:0001779) | 2.58436876 |
| 77 | adaptation of signaling pathway (GO:0023058) | 2.57831286 |
| 78 | T cell migration (GO:0072678) | 2.57392543 |
| 79 | protein targeting to Golgi (GO:0000042) | 2.56478406 |
| 80 | establishment of protein localization to Golgi (GO:0072600) | 2.55944355 |
| 81 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.55128653 |
| 82 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.54482496 |
| 83 | protein polyglutamylation (GO:0018095) | 2.53728197 |
| 84 | embryonic hemopoiesis (GO:0035162) | 2.52931459 |
| 85 | histone H3-K9 methylation (GO:0051567) | 2.52837258 |
| 86 | peptidyl-lysine trimethylation (GO:0018023) | 2.50735656 |
| 87 | rRNA catabolic process (GO:0016075) | 2.48713915 |
| 88 | histone H3-K9 modification (GO:0061647) | 2.48005087 |
| 89 | DNA deamination (GO:0045006) | 2.46946015 |
| 90 | regulation of T-helper 1 type immune response (GO:0002825) | 2.46785938 |
| 91 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.45017477 |
| 92 | mitochondrion distribution (GO:0048311) | 2.44683148 |
| 93 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.44681093 |
| 94 | auditory receptor cell differentiation (GO:0042491) | 2.43950082 |
| 95 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.43652196 |
| 96 | neuron cell-cell adhesion (GO:0007158) | 2.41454786 |
| 97 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.40124467 |
| 98 | regulation of mRNA catabolic process (GO:0061013) | 2.39387426 |
| 99 | regulation of action potential (GO:0098900) | 2.39000553 |
| 100 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.36964309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.04347479 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.99692408 |
| 3 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.71451742 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.13467330 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.08987298 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.72225035 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.53903553 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.53185176 |
| 9 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.16957934 |
| 10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.02265337 |
| 11 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.01440399 |
| 12 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.95861968 |
| 13 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.91620056 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.84455551 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.83394649 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.75159250 |
| 17 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.73495462 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.71730939 |
| 19 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.69707881 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.63288794 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.62578756 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.61500529 |
| 23 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.59148058 |
| 24 | FUS_26573619_Chip-Seq_HEK293_Human | 1.58142403 |
| 25 | GATA3_26560356_Chip-Seq_TH2_Human | 1.53667651 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.53571169 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.52704958 |
| 28 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50821595 |
| 29 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.50295238 |
| 30 | STAT3_23295773_ChIP-Seq_U87_Human | 1.47676198 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.47670590 |
| 32 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.46872963 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.46708376 |
| 34 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.45691776 |
| 35 | EWS_26573619_Chip-Seq_HEK293_Human | 1.44393475 |
| 36 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.42224114 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.41798761 |
| 38 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.41766759 |
| 39 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.41309418 |
| 40 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.39974758 |
| 41 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.39699451 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.37275163 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.34548816 |
| 44 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.31788556 |
| 45 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.31552820 |
| 46 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.31097091 |
| 47 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.31035790 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.30509725 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.30056373 |
| 50 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.25264307 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.23449823 |
| 52 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.21729627 |
| 53 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.20481213 |
| 54 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20481213 |
| 55 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.17669299 |
| 56 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17480938 |
| 57 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.17298777 |
| 58 | GATA3_26560356_Chip-Seq_TH1_Human | 1.16152677 |
| 59 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16094193 |
| 60 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.15645517 |
| 61 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15323891 |
| 62 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.14999657 |
| 63 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.13940795 |
| 64 | P300_19829295_ChIP-Seq_ESCs_Human | 1.13719504 |
| 65 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.13560101 |
| 66 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12134035 |
| 67 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.07726577 |
| 68 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07569601 |
| 69 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.05257482 |
| 70 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04738847 |
| 71 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.04413257 |
| 72 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04271979 |
| 73 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04271979 |
| 74 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.02687586 |
| 75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01882607 |
| 76 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00290392 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00262128 |
| 78 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99701115 |
| 79 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.99335447 |
| 80 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99029312 |
| 81 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98441060 |
| 82 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98067546 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.97848875 |
| 84 | NCOR_22424771_ChIP-Seq_293T_Human | 0.97530011 |
| 85 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97064585 |
| 86 | RXR_22108803_ChIP-Seq_LS180_Human | 0.95791574 |
| 87 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.95257434 |
| 88 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.94682799 |
| 89 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.93660064 |
| 90 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93578458 |
| 91 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.93039397 |
| 92 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92572994 |
| 93 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.92521878 |
| 94 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91599749 |
| 95 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.91033099 |
| 96 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.90580865 |
| 97 | MAF_26560356_Chip-Seq_TH2_Human | 0.90470387 |
| 98 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.88753296 |
| 99 | UTX_26944678_Chip-Seq_JUKART_Human | 0.88094024 |
| 100 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.88011988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 3.77754358 |
| 2 | MP0005360_urolithiasis | 3.07007502 |
| 3 | MP0005075_abnormal_melanosome_morpholog | 2.64726487 |
| 4 | MP0008877_abnormal_DNA_methylation | 2.63105168 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.58009305 |
| 6 | MP0005671_abnormal_response_to | 2.54278193 |
| 7 | MP0004885_abnormal_endolymph | 2.39045481 |
| 8 | MP0004381_abnormal_hair_follicle | 2.37847559 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.27240472 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.23694129 |
| 11 | MP0001986_abnormal_taste_sensitivity | 2.22916646 |
| 12 | MP0003880_abnormal_central_pattern | 2.11159303 |
| 13 | MP0000015_abnormal_ear_pigmentation | 2.05391831 |
| 14 | MP0001800_abnormal_humoral_immune | 2.01333147 |
| 15 | MP0008057_abnormal_DNA_replication | 1.96076152 |
| 16 | MP0000372_irregular_coat_pigmentation | 1.88323273 |
| 17 | MP0002102_abnormal_ear_morphology | 1.82813602 |
| 18 | MP0005310_abnormal_salivary_gland | 1.81825398 |
| 19 | MP0003646_muscle_fatigue | 1.69487582 |
| 20 | MP0009046_muscle_twitch | 1.68721433 |
| 21 | MP0002638_abnormal_pupillary_reflex | 1.65742604 |
| 22 | MP0002876_abnormal_thyroid_physiology | 1.65708302 |
| 23 | MP0002095_abnormal_skin_pigmentation | 1.62823641 |
| 24 | MP0006292_abnormal_olfactory_placode | 1.62244287 |
| 25 | MP0003787_abnormal_imprinting | 1.56312498 |
| 26 | MP0004142_abnormal_muscle_tone | 1.55522262 |
| 27 | MP0005551_abnormal_eye_electrophysiolog | 1.53705092 |
| 28 | MP0001790_abnormal_immune_system | 1.52039871 |
| 29 | MP0005387_immune_system_phenotype | 1.52039871 |
| 30 | MP0001835_abnormal_antigen_presentation | 1.50885549 |
| 31 | MP0004742_abnormal_vestibular_system | 1.49862305 |
| 32 | MP0002822_catalepsy | 1.48638674 |
| 33 | MP0000778_abnormal_nervous_system | 1.47423866 |
| 34 | MP0002723_abnormal_immune_serum | 1.43358025 |
| 35 | MP0004043_abnormal_pH_regulation | 1.37575621 |
| 36 | MP0002736_abnormal_nociception_after | 1.37109224 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.34483551 |
| 38 | MP0008961_abnormal_basal_metabolism | 1.34008814 |
| 39 | MP0000631_abnormal_neuroendocrine_gland | 1.33387221 |
| 40 | MP0001819_abnormal_immune_cell | 1.32239524 |
| 41 | MP0006276_abnormal_autonomic_nervous | 1.30097299 |
| 42 | MP0003724_increased_susceptibility_to | 1.29341168 |
| 43 | MP0009745_abnormal_behavioral_response | 1.26896089 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.26179758 |
| 45 | MP0003136_yellow_coat_color | 1.25273459 |
| 46 | MP0002398_abnormal_bone_marrow | 1.25241468 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.25091659 |
| 48 | MP0005000_abnormal_immune_tolerance | 1.24688977 |
| 49 | MP0002064_seizures | 1.22716637 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.21897685 |
| 51 | MP0000685_abnormal_immune_system | 1.21142351 |
| 52 | MP0009278_abnormal_bone_marrow | 1.15153533 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.14163585 |
| 54 | MP0002405_respiratory_system_inflammati | 1.13779220 |
| 55 | MP0001486_abnormal_startle_reflex | 1.09871178 |
| 56 | MP0000716_abnormal_immune_system | 1.09070472 |
| 57 | MP0000427_abnormal_hair_cycle | 1.07428082 |
| 58 | MP0008995_early_reproductive_senescence | 1.06354357 |
| 59 | MP0008058_abnormal_DNA_repair | 1.06055119 |
| 60 | MP0001984_abnormal_olfaction | 1.05942052 |
| 61 | MP0002751_abnormal_autonomic_nervous | 1.05747232 |
| 62 | MP0000371_diluted_coat_color | 1.05480657 |
| 63 | MP0005386_behavior/neurological_phenoty | 1.03657251 |
| 64 | MP0004924_abnormal_behavior | 1.03657251 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 1.02848816 |
| 66 | MP0002928_abnormal_bile_duct | 1.01883052 |
| 67 | MP0002063_abnormal_learning/memory/cond | 1.01683560 |
| 68 | MP0003635_abnormal_synaptic_transmissio | 1.01544892 |
| 69 | MP0003436_decreased_susceptibility_to | 1.01049045 |
| 70 | MP0002067_abnormal_sensory_capabilities | 0.99103532 |
| 71 | MP0002272_abnormal_nervous_system | 0.99055469 |
| 72 | MP0001905_abnormal_dopamine_level | 0.96549213 |
| 73 | MP0002234_abnormal_pharynx_morphology | 0.95857056 |
| 74 | MP0002557_abnormal_social/conspecific_i | 0.94936284 |
| 75 | MP0006082_CNS_inflammation | 0.94563872 |
| 76 | MP0003866_abnormal_defecation | 0.93632218 |
| 77 | MP0001529_abnormal_vocalization | 0.93304469 |
| 78 | MP0002722_abnormal_immune_system | 0.92239952 |
| 79 | MP0005253_abnormal_eye_physiology | 0.91172171 |
| 80 | MP0005174_abnormal_tail_pigmentation | 0.90949785 |
| 81 | MP0002572_abnormal_emotion/affect_behav | 0.89184723 |
| 82 | MP0005645_abnormal_hypothalamus_physiol | 0.87269716 |
| 83 | MP0003938_abnormal_ear_development | 0.85093708 |
| 84 | MP0003121_genomic_imprinting | 0.84685575 |
| 85 | MP0000613_abnormal_salivary_gland | 0.83830984 |
| 86 | MP0002163_abnormal_gland_morphology | 0.80835159 |
| 87 | MP0005367_renal/urinary_system_phenotyp | 0.80820567 |
| 88 | MP0000516_abnormal_urinary_system | 0.80820567 |
| 89 | MP0005025_abnormal_response_to | 0.76882877 |
| 90 | MP0001348_abnormal_lacrimal_gland | 0.76302344 |
| 91 | MP0000538_abnormal_urinary_bladder | 0.76199442 |
| 92 | MP0002419_abnormal_innate_immunity | 0.75891074 |
| 93 | MP0005499_abnormal_olfactory_system | 0.74400273 |
| 94 | MP0005394_taste/olfaction_phenotype | 0.74400273 |
| 95 | MP0003698_abnormal_male_reproductive | 0.73020284 |
| 96 | MP0002429_abnormal_blood_cell | 0.70971702 |
| 97 | MP0008789_abnormal_olfactory_epithelium | 0.70611287 |
| 98 | MP0004811_abnormal_neuron_physiology | 0.70257518 |
| 99 | MP0001501_abnormal_sleep_pattern | 0.70066978 |
| 100 | MP0001502_abnormal_circadian_rhythm | 0.70024394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the lower motor neuron (HP:0002366) | 4.04073260 |
| 2 | Medial flaring of the eyebrow (HP:0010747) | 3.89461186 |
| 3 | Congenital stationary night blindness (HP:0007642) | 3.89360048 |
| 4 | Hypothermia (HP:0002045) | 3.50388375 |
| 5 | Abnormality of the labia minora (HP:0012880) | 3.46115900 |
| 6 | Stomatitis (HP:0010280) | 3.45021472 |
| 7 | Amyotrophic lateral sclerosis (HP:0007354) | 3.31162003 |
| 8 | Type II lissencephaly (HP:0007260) | 2.96476052 |
| 9 | Panhypogammaglobulinemia (HP:0003139) | 2.96035325 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.94234542 |
| 11 | Limb dystonia (HP:0002451) | 2.93255364 |
| 12 | Generalized hypopigmentation of hair (HP:0011358) | 2.84650849 |
| 13 | Lissencephaly (HP:0001339) | 2.81670701 |
| 14 | Fair hair (HP:0002286) | 2.80306708 |
| 15 | Hyperventilation (HP:0002883) | 2.78201039 |
| 16 | Renal cortical cysts (HP:0000803) | 2.73191231 |
| 17 | Optic neuritis (HP:0100653) | 2.64717285 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 2.64717285 |
| 19 | Protruding tongue (HP:0010808) | 2.63154807 |
| 20 | Limb hypertonia (HP:0002509) | 2.60230580 |
| 21 | Pachygyria (HP:0001302) | 2.60039481 |
| 22 | Gaze-evoked nystagmus (HP:0000640) | 2.58561167 |
| 23 | Abnormal pupillary function (HP:0007686) | 2.55352547 |
| 24 | Volvulus (HP:0002580) | 2.50670102 |
| 25 | Abnormality of the renal cortex (HP:0011035) | 2.50560480 |
| 26 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.49639731 |
| 27 | Gait imbalance (HP:0002141) | 2.44163879 |
| 28 | Nephrogenic diabetes insipidus (HP:0009806) | 2.41255358 |
| 29 | Congenital primary aphakia (HP:0007707) | 2.37299781 |
| 30 | Abnormal hair whorl (HP:0010721) | 2.30931738 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 2.29530950 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.29530950 |
| 33 | Recurrent fungal infections (HP:0002841) | 2.29441260 |
| 34 | Decreased central vision (HP:0007663) | 2.29002331 |
| 35 | Myositis (HP:0100614) | 2.27640876 |
| 36 | Cerebellar dysplasia (HP:0007033) | 2.25949950 |
| 37 | IgG deficiency (HP:0004315) | 2.24340755 |
| 38 | Impaired proprioception (HP:0010831) | 2.22690110 |
| 39 | Progressive inability to walk (HP:0002505) | 2.21342506 |
| 40 | Focal motor seizures (HP:0011153) | 2.21097295 |
| 41 | Oligodactyly (hands) (HP:0001180) | 2.19352894 |
| 42 | Retinal dysplasia (HP:0007973) | 2.18591640 |
| 43 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.17934056 |
| 44 | Short 1st metacarpal (HP:0010034) | 2.17934056 |
| 45 | Nephronophthisis (HP:0000090) | 2.14651298 |
| 46 | Pancreatic cysts (HP:0001737) | 2.12691024 |
| 47 | True hermaphroditism (HP:0010459) | 2.12130249 |
| 48 | Orchitis (HP:0100796) | 2.06806792 |
| 49 | Hypoplastic iliac wings (HP:0002866) | 2.04588656 |
| 50 | Abnormality of T cells (HP:0002843) | 2.04465687 |
| 51 | Pustule (HP:0200039) | 2.03958482 |
| 52 | Upper motor neuron abnormality (HP:0002127) | 2.03192728 |
| 53 | Abnormality of the renal medulla (HP:0100957) | 2.02921909 |
| 54 | Abnormality of the pubic bones (HP:0003172) | 2.02807016 |
| 55 | Absent speech (HP:0001344) | 2.02401294 |
| 56 | Broad-based gait (HP:0002136) | 1.99439104 |
| 57 | Pancreatic fibrosis (HP:0100732) | 1.97237633 |
| 58 | Abnormality of T cell physiology (HP:0011840) | 1.97179601 |
| 59 | Abnormality of the metopic suture (HP:0005556) | 1.97032347 |
| 60 | Poor coordination (HP:0002370) | 1.94983539 |
| 61 | Tented upper lip vermilion (HP:0010804) | 1.93586317 |
| 62 | Abnormality of lateral ventricle (HP:0030047) | 1.92740816 |
| 63 | Inability to walk (HP:0002540) | 1.91358599 |
| 64 | Rib fusion (HP:0000902) | 1.90788422 |
| 65 | Clumsiness (HP:0002312) | 1.90412521 |
| 66 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.88562520 |
| 67 | Gastrointestinal infarctions (HP:0005244) | 1.88356823 |
| 68 | Stomach cancer (HP:0012126) | 1.86000758 |
| 69 | Shawl scrotum (HP:0000049) | 1.85093263 |
| 70 | Prominent nasal bridge (HP:0000426) | 1.82881443 |
| 71 | Abnormality of the 1st metacarpal (HP:0010009) | 1.82523673 |
| 72 | Abnormality of T cell number (HP:0011839) | 1.81853650 |
| 73 | Abnormality of the anterior horn cell (HP:0006802) | 1.81088942 |
| 74 | Degeneration of anterior horn cells (HP:0002398) | 1.81088942 |
| 75 | Vaginal atresia (HP:0000148) | 1.80370459 |
| 76 | Widely spaced teeth (HP:0000687) | 1.79564166 |
| 77 | Abnormality of macular pigmentation (HP:0008002) | 1.78502336 |
| 78 | Hip dysplasia (HP:0001385) | 1.77248145 |
| 79 | Genital tract atresia (HP:0001827) | 1.77071551 |
| 80 | Optic nerve hypoplasia (HP:0000609) | 1.76166423 |
| 81 | Severe combined immunodeficiency (HP:0004430) | 1.75959253 |
| 82 | Ocular albinism (HP:0001107) | 1.75589299 |
| 83 | Truncal obesity (HP:0001956) | 1.75150743 |
| 84 | Abnormality of eosinophils (HP:0001879) | 1.74391342 |
| 85 | Severe muscular hypotonia (HP:0006829) | 1.73786932 |
| 86 | Postaxial hand polydactyly (HP:0001162) | 1.73621932 |
| 87 | Iris hypopigmentation (HP:0007730) | 1.72552951 |
| 88 | Keratoconjunctivitis (HP:0001096) | 1.72516411 |
| 89 | Excessive salivation (HP:0003781) | 1.72281558 |
| 90 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.71907134 |
| 91 | Oculomotor apraxia (HP:0000657) | 1.71400611 |
| 92 | Drooling (HP:0002307) | 1.71323050 |
| 93 | Severe visual impairment (HP:0001141) | 1.71183180 |
| 94 | Gastroesophageal reflux (HP:0002020) | 1.70884452 |
| 95 | Short foot (HP:0001773) | 1.70360874 |
| 96 | T lymphocytopenia (HP:0005403) | 1.70008881 |
| 97 | Abnormality of incisor morphology (HP:0011063) | 1.68865157 |
| 98 | Intellectual disability, progressive (HP:0006887) | 1.68797880 |
| 99 | Progressive cerebellar ataxia (HP:0002073) | 1.67849703 |
| 100 | Atonic seizures (HP:0010819) | 1.67716169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K2 | 4.62068126 |
| 2 | TAOK3 | 3.26161793 |
| 3 | PINK1 | 3.05669942 |
| 4 | MAP4K1 | 2.89002379 |
| 5 | SIK2 | 2.39681796 |
| 6 | TXK | 2.21860413 |
| 7 | MARK1 | 2.21551208 |
| 8 | MAP3K4 | 2.05816361 |
| 9 | MAPK13 | 1.86768744 |
| 10 | MARK3 | 1.85243601 |
| 11 | WNK3 | 1.78830395 |
| 12 | FES | 1.77367438 |
| 13 | CASK | 1.76721905 |
| 14 | CDK6 | 1.62918418 |
| 15 | TNK2 | 1.61181747 |
| 16 | NTRK2 | 1.59911083 |
| 17 | ADRBK2 | 1.50810393 |
| 18 | IRAK4 | 1.50252007 |
| 19 | WNK4 | 1.43508491 |
| 20 | IRAK1 | 1.42254706 |
| 21 | SIK3 | 1.37606123 |
| 22 | GRK1 | 1.34128107 |
| 23 | ITK | 1.32812681 |
| 24 | CDK4 | 1.31622567 |
| 25 | PAK3 | 1.31334768 |
| 26 | BCR | 1.31191306 |
| 27 | WNK1 | 1.30001500 |
| 28 | ZAK | 1.27273014 |
| 29 | BRD4 | 1.25988539 |
| 30 | NTRK3 | 1.25888318 |
| 31 | SYK | 1.24046614 |
| 32 | YES1 | 1.19491706 |
| 33 | MAP2K7 | 1.18918821 |
| 34 | BLK | 1.15300981 |
| 35 | IKBKE | 1.10771494 |
| 36 | MUSK | 1.09693681 |
| 37 | FRK | 1.08384208 |
| 38 | EIF2AK1 | 1.06701984 |
| 39 | TYRO3 | 1.04691633 |
| 40 | TYK2 | 1.00121133 |
| 41 | CDK3 | 0.99403720 |
| 42 | PNCK | 0.98078396 |
| 43 | NEK6 | 0.97787002 |
| 44 | JAK3 | 0.97394905 |
| 45 | FGFR3 | 0.96200423 |
| 46 | PRKD2 | 0.95973268 |
| 47 | BTK | 0.91858306 |
| 48 | GRK6 | 0.91088347 |
| 49 | RPS6KA4 | 0.90213011 |
| 50 | NEK9 | 0.88826581 |
| 51 | IKBKB | 0.87003255 |
| 52 | FGR | 0.85486175 |
| 53 | BMPR1B | 0.85045175 |
| 54 | RIPK4 | 0.84812864 |
| 55 | SGK2 | 0.82990274 |
| 56 | DYRK3 | 0.80395621 |
| 57 | JAK1 | 0.78585757 |
| 58 | MAP3K14 | 0.78551333 |
| 59 | HCK | 0.78415815 |
| 60 | KSR1 | 0.77687045 |
| 61 | PRKCQ | 0.76294627 |
| 62 | DYRK2 | 0.73748023 |
| 63 | NLK | 0.71499573 |
| 64 | MAP2K2 | 0.70932136 |
| 65 | CSNK1G1 | 0.69853852 |
| 66 | LYN | 0.69643373 |
| 67 | TEC | 0.67949074 |
| 68 | PIM1 | 0.67771735 |
| 69 | CHUK | 0.65305467 |
| 70 | FGFR4 | 0.64172467 |
| 71 | MAP3K7 | 0.63180880 |
| 72 | PASK | 0.63013277 |
| 73 | JAK2 | 0.61593892 |
| 74 | LCK | 0.61547022 |
| 75 | PLK2 | 0.61368017 |
| 76 | PRKD3 | 0.60436756 |
| 77 | DYRK1A | 0.60325892 |
| 78 | PRKCH | 0.59594352 |
| 79 | DYRK1B | 0.59269042 |
| 80 | CAMKK2 | 0.56002459 |
| 81 | CSNK1G2 | 0.53274060 |
| 82 | SGK494 | 0.51222715 |
| 83 | SGK223 | 0.51222715 |
| 84 | CSF1R | 0.50982834 |
| 85 | CSNK1G3 | 0.50014343 |
| 86 | CSNK1A1L | 0.49263192 |
| 87 | FGFR2 | 0.47358610 |
| 88 | CAMK4 | 0.46704860 |
| 89 | PRPF4B | 0.45276998 |
| 90 | ATR | 0.44456328 |
| 91 | EIF2AK3 | 0.43669144 |
| 92 | MAPK9 | 0.43585412 |
| 93 | STK11 | 0.42877020 |
| 94 | PDK2 | 0.41881610 |
| 95 | PRKCZ | 0.40563084 |
| 96 | INSRR | 0.39695709 |
| 97 | IRAK2 | 0.37760246 |
| 98 | RPS6KA5 | 0.37303750 |
| 99 | ERBB2 | 0.36972226 |
| 100 | ABL1 | 0.36572290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.72394935 |
| 2 | Basal transcription factors_Homo sapiens_hsa03022 | 2.91133053 |
| 3 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.51505946 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.48890712 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.21302890 |
| 6 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.14651683 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.05072995 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.73440834 |
| 9 | Cocaine addiction_Homo sapiens_hsa05030 | 1.71201530 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 1.70841145 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.68019239 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.61638797 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60910999 |
| 14 | RNA degradation_Homo sapiens_hsa03018 | 1.58872737 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.55796811 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.52482633 |
| 17 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.46182389 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.39894132 |
| 19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.39297739 |
| 20 | RNA polymerase_Homo sapiens_hsa03020 | 1.38615151 |
| 21 | Lysine degradation_Homo sapiens_hsa00310 | 1.37321267 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.36808916 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.36036607 |
| 24 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.32364746 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.28518306 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27381340 |
| 27 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.26641547 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26221217 |
| 29 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.25553995 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.24483768 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21714946 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18344683 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.17074366 |
| 34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.17032984 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13903174 |
| 36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.09903344 |
| 37 | Circadian rhythm_Homo sapiens_hsa04710 | 1.07935382 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03705402 |
| 39 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.03411640 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02859080 |
| 41 | Allograft rejection_Homo sapiens_hsa05330 | 1.01460029 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.01248464 |
| 43 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00832528 |
| 44 | GABAergic synapse_Homo sapiens_hsa04727 | 1.00773976 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.00495307 |
| 46 | Protein export_Homo sapiens_hsa03060 | 1.00436906 |
| 47 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.98913320 |
| 48 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.91613211 |
| 49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89255273 |
| 50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89046555 |
| 51 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.88258289 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85209740 |
| 53 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84909620 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 0.84408453 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82929646 |
| 56 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.82691652 |
| 57 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.81449060 |
| 58 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.80292651 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 0.79750605 |
| 60 | Circadian entrainment_Homo sapiens_hsa04713 | 0.75389475 |
| 61 | Influenza A_Homo sapiens_hsa05164 | 0.72546361 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72089170 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69765296 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68310070 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67357138 |
| 66 | Spliceosome_Homo sapiens_hsa03040 | 0.66967758 |
| 67 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.66869466 |
| 68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65064063 |
| 69 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.64114216 |
| 70 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.64113246 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62840392 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61990174 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.58286793 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57716419 |
| 75 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.56547215 |
| 76 | Salivary secretion_Homo sapiens_hsa04970 | 0.54955668 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54638408 |
| 78 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54389538 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.54185901 |
| 80 | Tuberculosis_Homo sapiens_hsa05152 | 0.53348218 |
| 81 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51287804 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50501628 |
| 83 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49903601 |
| 84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49479883 |
| 85 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.48906998 |
| 86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48424803 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47324887 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47119434 |
| 89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46656973 |
| 90 | Leishmaniasis_Homo sapiens_hsa05140 | 0.45649995 |
| 91 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43931508 |
| 92 | Asthma_Homo sapiens_hsa05310 | 0.43631105 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43206946 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43127211 |
| 95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.43014949 |
| 96 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41678381 |
| 97 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.41299767 |
| 98 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.41229982 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40219497 |
| 100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37929880 |

